NDAORALTABLET
Approved
Apr 1961
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 31m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TINDAL (acetophenazine maleate) is an oral antipsychotic tablet approved in 1961 for treating psychotic disorders. It belongs to the phenothiazine class of first-generation antipsychotics and works by blocking dopamine receptors in the central nervous system. This legacy medication represents an early standard of care in psychiatry before modern atypical antipsychotics became dominant.
LOE Approaching
With LOE approaching and limited commercial data available, career opportunities are shrinking; positions focus on maintenance and compliance rather than growth or expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TINDAL offers limited career advancement opportunity; roles are defensive and focused on maintaining legacy market position rather than growth. This assignment is best suited for early-career professionals seeking foundational commercial or regulatory experience, or specialists managing mature/generics portfolios.
Brand ManagerMarket Access/Reimbursement Specialist
Worked on TINDAL at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.